International Journal of Cancer Management

Published by: Kowsar

Serum Levels of Selenium and Zinc in Patients with Breast Cancer: A Case-Control Study

Seyed-Mehdi Hashemi 1 , Masoud Sadeghi 2 , Abdolbaset Vahedi Tabas 3 , Salehoddin Bouya 1 , Hosein Ali Danesh 4 , Alireza Khazaei 4 and Abolghasem Allahyari 5 , *
Authors Information
1 Clinical Immunology Research Center, Ali-ebne Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
3 Student’s Scientific Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
4 Department of Surgery, Zahedan University of Medical Sciences, Zahedan, IR Iran
5 Department of Hematology and Medical Oncology, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • International Journal of Cancer Management: December 2017, 10 (12); e11463
  • Published Online: December 31, 2017
  • Article Type: Research Article
  • Received: March 14, 2017
  • Revised: November 18, 2017
  • Accepted: December 24, 2017
  • DOI: 10.5812/ijcm.11463

To Cite: Hashemi S, Sadeghi M, Vahedi Tabas A, Bouya S, Danesh H A, et al. Serum Levels of Selenium and Zinc in Patients with Breast Cancer: A Case-Control Study, Int J Cancer Manag. 2017 ;10(12):e11463. doi: 10.5812/ijcm.11463.

Copyright: Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Rezaei M, Hashemi M, Hashemi SM, Mashhadi MA, Taheri M. APOBEC3 Deletion is Associated with Breast Cancer Risk in a Sample of Southeast Iranian Population. Int J Mol Cell Med. 2015;4(2):103-8. [PubMed: 26261799].
  • 2. Payandeh M, Shazad B, Madani S, Ramezani M, Sadeghi M. Androgen Receptor Expression and its Correlation with Other Risk Factors in Triple Negative Breast Cancers: a Report from Western Iran. Asian Pac J Cancer Prev. 2016;17(7):3321-4. [PubMed: 27509970].
  • 3. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2(3):133-40. doi: 10.1016/S1470-2045(00)00254-0. [PubMed: 11902563].
  • 4. Moheb Afzali F, Tahmasebi Fard Z, Akbari ME. The Effect of Polymorphisms on the Ala 119 Ser Gene Cytochrome P450 1B1*2 on the Susceptibility of Iranian Women to Develop Breast Cancer. Int J Cancer Manag. 2017;10(3). doi: 10.5812/ijcp.4042.
  • 5. Hashemi M, Amininia S, Ebrahimi M, Hashemi SM, Taheri M, Ghavami S. Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population. BMC Res Notes. 2014;7:895. doi: 10.1186/1756-0500-7-895. [PubMed: 25491902].
  • 6. Hashemi M, Yousefi J, Hashemi SM, Amininia S, Ebrahimi M, Taheri M, et al. Association between Programmed Cell Death 6 Interacting Protein Insertion/Deletion Polymorphism and the Risk of Breast Cancer in a Sample of Iranian Population. Dis Markers. 2015;2015:854621. doi: 10.1155/2015/854621. [PubMed: 26063962].
  • 7. Hashemi SM, Arbabi N, Hashemi M, Mashhadi MA, Allahyari A, Sadeghi M. Association between VDR Gene Polymorphisms (rs 1544410, rs 7975232, rs 2228570, rs 731236 and rs 11568820) and Susceptibility to Breast Cancer in a Sample of Southeastern Iranian Population. Int J Cancer Manag. 2017;10(3). doi: 10.5812/ijcm.8807.
  • 8. Ding X, Jiang M, Jing H, Sheng W, Wang X, Han J, et al. Analysis of serum levels of 15 trace elements in breast cancer patients in Shandong, China. Environ Sci Pollut Res Int. 2015;22(10):7930-5. doi: 10.1007/s11356-014-3970-9. [PubMed: 25520207].
  • 9. Grattan BJ, Freake HC. Zinc and cancer: implications for LIV-1 in breast cancer. Nutrients. 2012;4(7):648-75. doi: 10.3390/nu4070648. [PubMed: 22852056].
  • 10. Chandler P, Kochupurakkal BS, Alam S, Richardson AL, Soybel DI, Kelleher SL. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer. Mol Cancer. 2016;15:2. doi: 10.1186/s12943-015-0486-y. [PubMed: 26728511].
  • 11. Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem. 2004;15(10):572-8. doi: 10.1016/j.jnutbio.2004.07.005. [PubMed: 15542347].
  • 12. Stipanuk MH. Biochemical, Physiological, and Molecular Aspects of Human Nutrition. 2006.
  • 13. Chen YC, Prabhu KS, Das A, Mastro AM. Dietary selenium supplementation modifies breast tumor growth and metastasis. Int J Cancer. 2013;133(9):2054-64. doi: 10.1002/ijc.28224. [PubMed: 23613334].
  • 14. Guido LN, Fontelles CC, Rosim MP, Pires VC, Cozzolino SM, Castro IA, et al. Paternal selenium deficiency but not supplementation during preconception alters mammary gland development and 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in female rat offspring. Int J Cancer. 2016;139(8):1873-82. doi: 10.1002/ijc.30223. [PubMed: 27270969].
  • 15. Pasco JA, Nicholson GC, Brennan SL, Kotowicz MA. Prevalence of obesity and the relationship between the body mass index and body fat: cross-sectional, population-based data. PLoS One. 2012;7(1). e29580. doi: 10.1371/journal.pone.0029580. [PubMed: 22253741].
  • 16. Atoum MF, Hourani HM, Shoter A, Al-Raheem SN, Al Muhrib TK. TNM staging and classification (familial and nonfamilial) of breast cancer in Jordanian females. Indian J Cancer. 2010;47(2):194-8. doi: 10.4103/0019-509X.63022. [PubMed: 20448386].
  • 17. Rice-Evans C, Burdon R. Free radical-lipid interactions and their pathological consequences. Prog Lipid Res. 1993;32(1):71-110. [PubMed: 8415800].
  • 18. Klotz LO, Kroncke KD, Buchczyk DP, Sies H. Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J Nutr. 2003;133(5 Suppl 1):1448S-51S. [PubMed: 12730440].
  • 19. Hoang BX, Han B, Shaw DG, Nimni M. Zinc as a possible preventive and therapeutic agent in pancreatic, prostate, and breast cancer. Eur J Cancer Prev. 2016;25(5):457-61. doi: 10.1097/CEJ.0000000000000194. [PubMed: 26317381].
  • 20. Platz EA, Helzlsouer KJ. Selenium, zinc, and prostate cancer. Epidemiol Rev. 2001;23(1):93-101. [PubMed: 11588860].
  • 21. Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr. 2004;91(1):11-28. [PubMed: 14748935].
  • 22. Wallenberg M, Misra S, Bjornstedt M. Selenium cytotoxicity in cancer. Basic Clin Pharmacol Toxicol. 2014;114(5):377-86. doi: 10.1111/bcpt.12207. [PubMed: 24529300].
  • 23. Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213-8. doi: 10.1186/bcr921. [PubMed: 15318928].
  • 24. Greenlee H, White E, Patterson RE, Kristal AR, Lifestyle Study C.Vitamins. Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med. 2004;10(4):660-6. doi: 10.1089/acm.2004.10.660. [PubMed: 15353022].
  • 25. Garcia E, Hurley S, Nelson DO, Hertz A, Reynolds P. Hazardous air pollutants and breast cancer risk in California teachers: a cohort study. Environ Health. 2015;14:14. doi: 10.1186/1476-069X-14-14. [PubMed: 25636809].
  • 26. Kholousi Adab F, Tahmasebi Fard Z, Esmaeil Akbari M. Association Between Cytochrome 1B1*3 Polymorphism and the Breast Cancer in a Group of Iranian Women. Iran J Cancer Prevent. 2017;In Press(In Press). doi: 10.17795/ijcp-6428.
  • 27. Kuo HW, Chen SF, Wu CC, Chen DR, Lee JH. Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res. 2002;89(1):1-11. doi: 10.1385/BTER:89:1:1. [PubMed: 12413046].
  • 28. Wu HD, Chou SY, Chen DR, Kuo HW. Differentiation of serum levels of trace elements in normal and malignant breast patients. Biol Trace Elem Res. 2006;113(1):9-18. doi: 10.1385/BTER:113:1:19. [PubMed: 17114811].
  • 29. Pavithra V, Sathisha TG, Kasturi K, Mallika DS, Amos SJ, Ragunatha S. Serum levels of metal ions in female patients with breast cancer. J Clin Diagn Res. 2015;9(1):BC25-c27. doi: 10.7860/JCDR/2015/11627.5476. [PubMed: 25737978].
  • 30. Yucel I, Arpaci F, Ozet A, Doner B, Karayilanoglu T, Sayar A, et al. Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer. Biol Trace Elem Res. 1994;40(1):31-8. [PubMed: 7511919].
  • 31. Mir M, Mir P, Elmi S, Maleki M. Comparison of Serum Selenium Levels in Breast Cancer Patients and Healthy People at a Cancer Institute in 2004. SSUJ. 2007;14(4):2-8.
  • 32. Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L. Selenium in breast cancer. Oncology. 2003;64(3):227-31. doi: 10.1159/000069312. [PubMed: 12697962].
  • 33. Singh P, Kapil U, Shukla NK, Deo S, Dwivedi SN. Association between breast cancer and vitamin C, vitamin E and selenium levels: results of a case-control study in India. Asian Pac J Cancer Prev. 2005;6(2):177-80. [PubMed: 16101329].
  • 34. Bratakos MS, Vouterakos TP, Ioannou PV. Selenium status of cancer patients in Greece. Sci Total Environ. 1990;92:207-22. [PubMed: 2326622].
  • 35. Alatise OI, Babalola OO, Omoniyi-Esan GO, Lawal OO, Adesunkanmi AR, Agbakwuru EA. Selenium levels in neoplastic breast lesions. Niger Postgrad Med J. 2013;20(2):91-7. [PubMed: 23959347].
  • 36. Holtkamp W, Thiery J, Rauschecker H, Nagel GA, Reis HE. [Decreased plasma zinc levels in metastatic breast cancer]. Onkologie. 1990;13(3):207-9. [PubMed: 2204008].
  • 37. Zhang S, Li F, Younes M, Liu H, Chen C, Yao Q. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium. PLoS One. 2013;8(5). e63702. doi: 10.1371/journal.pone.0063702. [PubMed: 23704933].
  • 38. Riesop D, Hirner AV, Rusch P, Bankfalvi A. Zinc distribution within breast cancer tissue: A possible marker for histological grading?. J Cancer Res Clin Oncol. 2015;141(7):1321-31. doi: 10.1007/s00432-015-1932-3. [PubMed: 25672953].
  • 39. Kowalska E, Narod SA, Huzarski T, Zajaczek S, Huzarska J, Gorski B, et al. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1302-6. doi: 10.1158/1055-9965.EPI-03-0448. [PubMed: 15894690].
  • 40. Shah YM, Kaul A, Dong Y, Ip C, Rowan BG. Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression. Breast Cancer Res Treat. 2005;92(3):239-50. doi: 10.1007/s10549-005-3203-5. [PubMed: 16155795].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader